Table 1 Correlation between MIIP protein expression and pathological parameters of EC
From: MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis
Pathological characteristic | No. | MIIP expression, n (%) | χ 2 | P | |
|---|---|---|---|---|---|
Low | High | ||||
Histologic subtype | |||||
 Endometrioid | 183 | 126 (68.85) | 57 (31.15) | 1.827 | 0.176 |
 Non-endometrioid | 22 | 12 (54.55) | 10 (45.45) |  |  |
Histopathological grade | |||||
 1 | 82 | 58 (70.73) | 24 (29.27) | 0.204 | 0.903 |
 2 | 77 | 55 (71.43) | 22 (28.57) |  |  |
 3 | 24 | 16 (66.67) | 8 (22.33) |  |  |
FIGO stage | |||||
 I and II | 166 | 109 (65.77) | 57 (34.33) | 6.930 | 0.008 |
 III and IV | 39 | 34 (87.28) | 5 (12.82) |  |  |
Myometrial invasion | |||||
 <1/2 | 141 | 90 (63.83) | 51 (36.17) | 7.519 | 0.006 |
 ≥1/2 | 64 | 53 (82.01) | 11 (17.19) |  |  |
Lymph node status | |||||
 Negative | 179 | 110 (61.45) | 69 (38.55) | 5.312 | 0.021 |
 Positive | 26 | 22 (84.62) | 4 (15.38) |  |  |